These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31799361)

  • 61. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin.
    Toulon P; Boutière B; Horellou MH; Trzeciak MC; Samama MM
    Thromb Haemost; 1998 Jul; 80(1):104-8. PubMed ID: 9684794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of a point-of-care coagulation analyzer (Abaxis VSPro) for identification of coagulopathies in dogs.
    Dixon-Jimenez AC; Brainard BM; Cathcart CJ; Koenig A
    J Vet Emerg Crit Care (San Antonio); 2013; 23(4):402-7. PubMed ID: 23796019
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of hemolysis, icterus and lipemia on coagulation tests as performed on Cobas t511 new analyzer.
    Montaruli B; Guiotto C; Cosseddu D
    Blood Coagul Fibrinolysis; 2020 Jan; 31(1):48-54. PubMed ID: 31789660
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study.
    Gouin-Thibault I; Flaujac C; Delavenne X; Quenet S; Horellou MH; Laporte S; Siguret V; Lecompte T
    Thromb Haemost; 2014 Feb; 111(2):240-8. PubMed ID: 24172843
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.
    Stettler GR; Moore EE; Moore HB; Nunns GR; Coleman JR; Colvis A; Ghasabyan A; Cohen MJ; Silliman CC; Banerjee A; Sauaia A
    J Trauma Acute Care Surg; 2019 Sep; 87(3):582-589. PubMed ID: 31136528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy.
    Byun JH; Jang IS; Kim JW; Koh EH
    Blood Res; 2016 Sep; 51(3):171-174. PubMed ID: 27722127
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation and performance characteristics of the coagulation system: ACL TOP analyzer - HemosIL reagents.
    Milos M; Herak D; Kuric L; Horvat I; Zadro R
    Int J Lab Hematol; 2009 Feb; 31(1):26-35. PubMed ID: 19230204
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Prospective Study of Specialized Coagulation Parameters in Admitted COVID-19 Patients and Their Correlation With Acute Respiratory Distress Syndrome and Outcome.
    Sehgal T; Gupta N; Kohli S; Khurana A; Dass J; Diwan S; A J M; Khan M; Aggarwal M; Subramanian A
    Cureus; 2021 Aug; 13(8):e17463. PubMed ID: 34589359
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R; Grant RP; Adcock DM
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Should we abandon the APTT for monitoring unfractionated heparin?
    Arachchillage DRJ; Kamani F; Deplano S; Banya W; Laffan M
    Thromb Res; 2017 Sep; 157():157-161. PubMed ID: 28759760
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protocolled Redefinition of the Therapeutic Range for Unfractionated Heparin: Lost in Translation?
    Coene KLM; van der Graaf F; van de Kerkhof D
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):164-171. PubMed ID: 27856667
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children.
    Kuhle S; Eulmesekian P; Kavanagh B; Massicotte P; Vegh P; Lau A; Mitchell LG
    Haematologica; 2007 Apr; 92(4):554-7. PubMed ID: 17488668
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Evaluation of the coagulometer STA R Max
    Brulé J; Sinegre T; Pereira B; Berger MG; Serre-Sapin AF; Lebreton A
    Ann Biol Clin (Paris); 2018 Apr; 76(2):143-149. PubMed ID: 29623883
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Is it acceptable to use coagulation plasma samples stored at room temperature and 4°C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D-dimer testing?
    Rimac V; Coen Herak D
    Int J Lab Hematol; 2017 Oct; 39(5):475-481. PubMed ID: 28488785
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
    McGlasson DL
    Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sonoclot® evaluation of single- and multiple-dose subcutaneous unfractionated heparin therapy in healthy adult dogs.
    Babski DM; Brainard BM; Ralph AG; Pittman JR; Koenig A
    J Vet Intern Med; 2012; 26(3):631-8. PubMed ID: 22435404
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations.
    Kaserer A; Schedler A; Seifert B; Spahn DR; Studt JD; Stein P
    Perioper Med (Lond); 2019; 8():15. PubMed ID: 31832179
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogs.
    Diquélou A; Barbaste C; Gabaig AM; Trumel C; Abella-Bourges N; Guelfi JF; Bousquet Mélou A
    Vet Clin Pathol; 2005 Sep; 34(3):237-42. PubMed ID: 16134071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].
    Tschaikowsky K; Balint R; Pscheidl E; Bremer F
    Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.